Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II
|
|
- Shana Miles
- 6 years ago
- Views:
Transcription
1 Slov. Radiol. 16 (1), 2009, M. Malík 1, P. Lesný 1, J. Bilický 1, V. Slezák 2, V. Belan 3 1 I. rádiologická klinika LFUK a FNsP Bratislava, Nemocnica sv. Cyrila a Metoda Prednosta: Prof. MUDr. Jozef Bilický, CSc. 2 Oddelenie cievnej chirurgie, FNsP Bratislava, Nemocnica sv. Cyrila a Metoda Primár: MUDr. Viliam Slezák, CSc. 3 Rádiodiagnostická klinika, FNsP Bratislava, Nemocnica akad. L. Dérera Prednosta: MUDr. Víťazoslav Belan, PhD., host. doc. Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II Súhrn Neustále zdokonalovanie metód modernej intervenčnej radiológie vedie k rozširovaniu typov lézií vhodných na endovaskulárnu (EV) liečbu pri periférnom artériovom ochorení končatinových tepien (PAO). Cieľom článku je poskytnúť čitateľovi prehľad indikácii endovaskulárnej liečby chronických končatinových lézií podľa Transatlantického konsenzu (2007). Klúčové slová: endovaskulárna liečba, periférne artériové ochorenie, kritická končatinová ischémia, intermitentné klaudikácie, intervenčná radiológia Summary The improvement of the methods of interventional radiology leads to modifacations of lesions types in favor of endovascular treatment. The aim of this article is to provide the complex view of endovascular treatment indications according to recommendation published in Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (2007). Key words: endovascular therapy, peripheral arterial disease, critical limb ischemia, intermitent claudications, interventional radiology Úvod a základné údaje Pod termínom periférneho artériového ochorenia (PAO) sa rozumie ischemická choroba dolných končatín, ktorá je podľa klinického priebehu chronická alebo akútna. Chronická forma, najčastejšie spôsobená aterosklerózou, je spojená so zvýšenou kardiovaskulárnou morbiditou a mortalitou, ktorá je v porovnaní s bežnou populáciou niekoľkonásobne vyššia. Incidencia asymptomatickej formy tohoto ochorenia je 3 10 %, vo veku nad 70 rokov sa zvyšuje na %. Prevalencia PAO v štádiu intermitentných klaudikácií vo veku 60 rokov je 6 %. K rizikovým faktorom vzniku a rozvoja PAO patrí najmä fajčenie, diabetes mellitus, hypertenzia, dyslipidémia, vyšší vek, mužské pohlavie, čierna rasa, chronická renálna insuficiencia. Multifaktoriálny a systémový charakter príčiny tohoto ochorenia je jedným z dôvodov, prečo liečba PAO vyžaduje multidiciplinárny prístup Indikácie revaskularizačnej liečby pri PAO Kritická končatinová ischémia (CLI) je klinickou manifestáciou hemodynamicky najzávažnejšej chronickej končatinovej hypoperfúzie. Vyvinie sa, ak je prietok krvi redukovaný natoľko, že nepokryje bazálne okysličenie tkanív. Pri ťažkej hypoxii tkanív dochádza k rozvoju pokojových bolestí alebo kožných defektov. Výsledky viacerých multicentrických štúdií u podskupiny pacientov u ktorých zlyhal pokus o revaskularizáciu, alebo nebola možná ukazujú, že v priebehu 6 mesiacov približne 40 % z nich o končatinu prichádza a asi 20 % zomiera. Revaskularizácia je optimálnou primárnou liečbou pri kritickej končatinovej ischémii (Fontaine III, IV, Rutheford II., III./5, III./6) (tab. 1). Revaskularizačná liečba býva indikovaná aj v štádiu intermitentných klaudikácií, negatívne ovplyvňujúcich kvalitu života pacienta (najčastejšie v štádiu Fontaine II.B, Rutheford I./2., I/3); Pri výbere najlepšej metódy revaskularizácie pre liečbu symptomatického PAO je potrebné individuálne zvážiť u každého pacienta pomer profitu a rizika invazívneho liečebného zásahu. Pred rozhodnutím metódy revaskularizácie je nutná presná lokalizácia, rozsah a morfológia lézií (farbou kódovaná duplexná sonografia, MRA, CTA, digitálna subtrakčná angiografia). V situácii, kedy sa dá očakávať rovnaký efekt endovaskulárnej (EV) a chirurgickej liečby z krátkodobého aj dlhodobého hľadiska, prednosť má endovaskulárna liečba. TASC II TASC (Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease), ktorý bol publikovaný v januári 2000 mal veľký celosvetový ohlas
2 Kolektív: Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II 47 Tab. 1. Klasifikácia PAO podľa Fontainea a Rutherforda. Fontain Rutherford štádium klinické symptómy patofyziológia klinický stupeň kategória I. asymptomatické náhodné odhalenie aortálnych a iliakálnych kalcifikácií AS pláty rizikové pláty asymptomatické 0. 0 II.A mierna klaudikácia klaudikačná vzdialenosť >200 m čas zotavenia <2 min II.B III. IV. stredne ťažká alebo ťažká klaudikácia ischemická pokojová bolesť ischemická ulcerácia alebo gangréna klaudikačná vzdialenosť 200 m čas zotavenia >2 min klaudikačná vzdialenosť <100 m čas zotavenia >2 min diskrepancia medzi potrebou kyslíka a cievnym zásobením väčšia diskrepancia medzi potrebou kyslíka a cievnym zásobením najväčšia diskrepancia medzi potrebou kyslíka a cievnym zásobením + acidóza mierna klaudikácia I. 1 stredne ťažká I. 2 klaudikácia ťažká klaudikácia I. 3 ischemická pokojová bolesť ťažká kožná hypoxia a acidóza ischemická pokojová bolesť II. 4 nekróza ťažká kožná hypoxia, infekcia malá strata tkanív III. 5 gangréna ťažká kožná hypoxia, infekcia veľká strata III. 6 tkanív medzi vaskulárnymi špecialistami. TASC II (2007) bol iniciovaný už počas roku 2004 a je opäť zameraný na kľúčove aspekty diagnostiky a liečby, s väčším dôrazom na diabetes pri PAO. Súčasťou tohto komplexného dokumentu je súbor odporúčaní odstupňovaných podľa úrovne dôkazov založených na nových klinických štúdiách. Práve vzhľadom na ne a technické zdokonalenie endovaskulárneho inštrumentária boli lézie rozdelené v schémach pôvodnej TASC klasifikácie modifikované. Vo femoropopliteálnom úseku došlo k rozšíreniu typov lézii vhodných na EV revaskularizáciu, čo sa týka dĺžky nekalcifikovaných ako aj ťažko kalcifikovaných stenóz a oklúzií. Tento posun v prospech endovaskularnej oproti chirurgickej liečbe umožnili aj štúdie, ktoré dokázali dlhodobejšiu priechodnosť primárneho stentingu vo femoropoplitálnom úseku 8. Práve v tomto úseku sa osvedčili nové typy stentov s vysoko flexibilným skeletom a s dostatočnou radiálnou silou, odolných voči torzným silám a zalomeniu. TASC klasifikácia aorto-iliakálnych lézií Lézie typu A : uni/bilaterálna stenóza AIC uni/bilaterálna jednoduchá krátka stenóza AIE 3 cm Lézie typu B : Krátka stenóza infrarenálneho úseku aorty ( 3 cm) Unilaterálna oklúzia AIC Solitárna/viacpočetné stenózy AIC/AIE v celkovom rozsahu 3-10 cm nezasahujúce do AFC Unilaterálna oklúzia AIE nezasahujúca do odstupu AII a AFC TASC klasifikácia Lézie, ktoré majú výnikajúce výsledky pri endovaskulárnej liečbe sú v TASC klasifikácii zaradené do lézií typu A, lézie typu B majú z dlhodobého hladiska priechodnosti dobré výsledky pri endovaskulárnej liečbe, pri léziách typu C dosahuje tento cieľ chirurgická revaskularizácia. EV liečba tohto typu lézií by mala byť indikovaná len u vysokorizikových pacientov z hľadiska chirurgického výkonu. EV liečba by nemala byť indikovaná ako primárna pri léziách typu D. TASC A endovaskulárna revaskularizácia metóda voľby TASC B preferencia endovaskulárnej terapie TASC C preferencia chirurgickej terapie TASC D chirurgická revaskularizácia metóda voľby Lézie typu C : Bilaterálna okúzia AIC Bilaterálna stenóza AIE v celk. rozsahu 3-10 cm nezasahujúca do AFC Unilaterálna stenóza AIE zasahujúca do AFC
3 48 Kolektív: Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II Unilaterálna oklúzia AIE zasahujúca do odstupu AII a/ alebo do AFC Ťažko kalcifikovaná unilaterálna oklúzia AIE zasahujúca prípadne nezasahujúca do odstupu AII a/alebo do AFC Lézie typu D : Oklúzia infrarenálnej aorty Difúzne postihnutie aorty a oboch iliakálnych artérií vyžadujúce revaskularizáciu Viacpočetné stenózy AIC, AIE a AFC unilaterálne Unilaterálna oklúzia AIC spolu s AIE Bilaterálna oklúzia AIE Stenózy iliakálneho art. riečiska u pacientov s AAA, ktorá je indikovaná na liečbu, nevhodná na stentgraft Lézie typu B : Viacpočetné lézie (stenózy alebo oklúzie), každá v rozsahu 5 cm Solitárna stenóza/oklúzia 15 cm nezasahujúca do AP pod úroveň štrbiny kolenného kĺbu Solitárna alebo viacpočetné lézie pri obliterujúcich léziách krurálnych artérií na zvýšenie prítoku pre distálny bypass Ťažko kalcifikovaná oklúzia 5 cm Jednoduchá stenóza AP Lézie typu C : Viacpočetné kalcifikované/nekalcifikované stenózy alebo oklúzie v celkovom rozsahu >15 cm Restenózy / reoklúzie vyžadujúce revaskularizáciu po dvoch predchádzajúcich EV intervenciách AIC a.iliaca communis, AIE a.iliaca externa, AII a.iliaca interna, AFC a.femoralis communis, AAA aneuryzma abdominálnej aorty Schémy prebraté z JOURNAL OF VASCULAR SUR- GERY (Január 2007) TASC klasifikácia femoro-popliteálnych lézií Lézie typu D : Chronická oklúzia AFC/AFS (>20 cm, postihujúca AP) Chronická oklúzia AP a proximálnych úsekov krurálnych tepien Lézie typu A : Solitárna stenóza v dĺžke 10 cm Solitárna oklúzia v dĺžke 5 cm AFC a.femoralis superficialis, AFC a.femoralis communis, AP a.poplitea Schémy prebraté z JOURNAL OF VASCULAR SUR- GERY (Január 2007)
4 Kolektív: Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II 49 a. b. c. Obr. 1. TASC A lézia, tesná stenóza ľavej a.iliaca externa riešená implantáciou stentu; a. b. Obr. 2. TASC B lézia, oklúzia ľavej a.iliaca communis riešená rekanalizáciou a implantáciou stentu; Endovaskulárna liečba infrapopliteálnych lézií Vätšina pacientov s CLI má postihnutie tepien predkolenia, ktoré sa často kombinuje so stenotizujúcim alebo obliterujúcim procesom iliofemoropopliteálne. EV liečba infrapopliteálnych lézií je obyčajne indikovaná pri pokuse o záchranu končatiny, v súčasnoti je technicky možné dočasne (na dobu potrebnú pre zhojenie kožného defektu) rekanalizovať aj kompletne obliterované krurálne tepny. Na odporúčanie EV liečby v štádiu intermitentných klaudikácii je zatiaľ nedostatok dôkazov, aj keď sa vedú diskusie o predĺžení priechodnosti proximálnej PTA a zvýšení outflow. PTA krátkych stenóz je možné vykonať v spojení s popliteálnou resp. femorálnou angioplastikou. Záver Správna voľba najvhodnejšej metódy revaskularizácie môže zvýšiť šance záchrany končatiny pri kritickej končatinovej ischémii a zvýšiť kvalitu života pacienta s PAO v štádiu klaudikácii. Uvedené schémy sú limitované zameraním na konkrétne lézie. Väčšina pacientov s PAO vyžadujúcich revaskularizáciu má viac ako jednu léziu na rôznych úrovniach (multietážové postihnutie) a pridružené ochorenia. Preto je potrebné najmä pri TASC B a C léziách zvoliť individuálny prístup pri indikovaní EV, chirurgického prípadne hybridného výkonu. Do úvahy treba brať aj preferenciu pacienta a dlhodobé výsledky revaskularizačných výkonov konkrétneho pracoviska. Aj keď endovaskulárna liečba nerieši primárnu príčinu lézií, vo vätšine
5 50 Kolektív: Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II a. b. c. Obr. 4. TASC B lézia, segmentová oklúzia s následnou tesnou stenózou v distálnom úseku pravej AFS riešená rekanalizáciou a PTA so suboptimálnym efektom a následnou korekciou implantáciou samoexpandovateľného stentu. a. b. Obr. 3. TASC A lézia, krátka stenóza a.poplitea riešená PTA (perkutánna transluminálna angioplastika) a. b. Obr. 5. Stenózy a obliterácie krurálnych tepien, a. stenózy truncus tibiofibularis a proximálneho úseku a.fibularis, b. stav po dilatácii a. b. Obr. 6a. Krátka segmentová oklúzia proximálneho úseku a fokálna stenóza na rozhraní strednej a distálnej tretiny a.tibialis anterior (a.tibialis posterior a a.fibularis sú obliterované), b. stav po endovaskulárnej revaskularizácii (rekanalizácia a implantácia balónkom expandovateľného stentu, PTA distálnej stenózy)
6 Kolektív: Indikácie endovaskulárnej terapie chronických končatinových artériových lézií podľa TASC II 51 prípadov aterosklerózu, v budúcich rokoch môžme očakávať ďaľší rozvoj jej metód a inštrumentária a vyplývajúcu reklasifikáciu indikácii v prospech tejto menej invazívnej terapeutickej metódy. Literatúra 1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, and F.G.R. Fowkes on behalf of the TASC II Working Group. Inter-Society Consensus of the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 2007; 45(1): S 5A- 67A. 2. TASC. Management of Peripheral Arterial Disease (PAD) TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000; 31 (1 part 2): S Selvin E, Erlinger TP. Prevalence of and risk factor for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, Circulation 2004; 110 (6): Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20(2): Criqui M, Langer R, Fronek A, Feigelson H, Klauber M, McCann T, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: Nehler MR, Hiatt WR, Taylor LM Jr. Is revaskularization and limb salvage always the best treatment for critical limb ischemia? J Vasc Surg 2003;37(3): Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Ballon angioplasty versus implantation of nitinol stents in the superficial femoral artery, N Engl J Med 2006; 354 (18): Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C et al. Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Ballon Angioplasty With Optional Stenting, Circulation 2007; 115:
PAOO klinický význam, diagnostika a liečba. M.Širila, Angiologická amb.fn Trenčín Chirurgická klinika FNTN
PAOO klinický význam, diagnostika a liečba M.Širila, Angiologická amb.fn Trenčín Chirurgická klinika FNTN PAOO DEFINÍCIA funkčne - zúženie lumenu tepien, spôsobujúce nepomer medzi dodávkou kyslíka a jeho
More informationMaking the difference with Live Image Guidance
Live Image Guidance 2D Perfusion Making the difference with Live Image Guidance In Peripheral Arterial Disease Real-time results, instant assessment Severe foot complications the result of hampered blood
More informationThe incidence of peripheral artery disease (PAD)
Pharmacologic Options for Treating Restenosis The role of cilostazol in the treatment of patients with infrainguinal lesions. By Osamu Iida, MD, and Yoshimitsu Soga, MD The incidence of peripheral artery
More informationEndovenózna a lokálna liečba u pacientov s CVI C5 - C6
Endovenózna a lokálna liečba u pacientov s CVI C5 - C6 Torma N., Frankovičová M., Lacková V., Kopolovets G., Tormová Z. IMEA CC- Angiochirurgická ambulancia, Tichá 8, Košice Klinika cievnej chirurgie LF
More informationPeripheral Arterial Disease: the growing role of endovascular management
Peripheral Arterial Disease: the growing role of endovascular management Poster No.: C-1931 Congress: ECR 2012 Type: Educational Exhibit Authors: E. M. C. Guedes Pinto, E. Rosado, D. Penha, P. Cabral,
More informationAbstract. Key words: peripheral artery disease, lower limb, endovascular therapy, Iran
The evaluation of the success rate, complications and midterm follow up results of patients with peripheral arterial disease of lower limb treated using endovascular therapy: A single center study Mohammad
More informationOriginal Article INTRODUCTION
Original Article DOI: 10.3348/kjr.2011.12.2.203 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2011;12(2):203-209 The Primary Patency and Fracture Rates of Self- Expandable Nitinol Stents Placed in the
More informationEndovascular treatment of thrombosis (acute) of aneurysm through bifurcated endoprothesis: challenge cases
Endovascular treatment of thrombosis (acute) of aneurysm through bifurcated endoprothesis: challenge cases Fábio Luiz Costa Pereira Fabrício Machado Rossi Pablo da Silva Mendes Carlos Andre Daher Victor
More informationVaskulárna medicína. Odporúčania pre diagnostiku a liečbu periférneho artériového ochorenia dolných končatín PAO DK.
Vaskulárna medicína S2 2010 www.solen.sk ISSN 1338-0214 Odporúčania pre diagnostiku a liečbu periférneho artériového ochorenia dolných končatín PAO DK Odporúčania Tiráž 3 Odporúčania pre diagnostiku a
More informationOutcomes of endovascular treatment for patients with TASC II D femoropopliteal occlusive disease: a single center study
BMC Cardiovascular Disorders This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Outcomes of endovascular
More informationDiagnostika a liečba relabovaného a refraktérneho DLBCL
Diagnostika a liečba relabovaného a refraktérneho DLBCL Miriam Ladická Národný onkologický ústav Vysoká účinnosť Akceptovateľná Liečba ochorenia toxicita Minimálne neskoré NÚ cca 1/3 pacientov s DLBCL
More informationCurrent Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis
Current Status and Limitations in the Treatment of Femoropopliteal In-Stent Restenosis Osamu Iida, MD From the Kansai Rosai Hospital Cardiovascular Center, Amagasaki City, Japan. ABSTRACT: Approximately
More informationEndovascular treatment (EVT) has markedly advanced,
Ann Vasc Dis Vol. 6, No. 3; 2013; pp 573 577 Online August 12, 2013 2013 Annals of Vascular Diseases doi:10.3400/avd.oa.13-00055 Original Article A Review of Surgically Treated Patients with Obstruction
More informationDO NOT DUPLICATE. Critical limb ischemia (CLI) has been defined as patients with chronic. Endovascular Interventions for Limb Salvage REVIEW
REVIEW WOUNDS 2011;23(12):357 363 From the 1 Chief of Division, Vascular/Endovascular Surgery, St. Luke s-roosevelt Hospital and Associate Clinical Professor of Surgery, Columbia University, New York,
More informationStep by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery
Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following
More informationVascular Medicine. Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting
Vascular Medicine Sustained Benefit at 2 Years of Primary Femoropopliteal Stenting Compared With Balloon Angioplasty With Optional Stenting Martin Schillinger, MD; Schila Sabeti, MD; Petra Dick, MD; Jasmin
More informationUtility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery
Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu Soga, MD, a Osamu Iida, MD, b Keisuke Hirano, MD,
More informationHybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results.
Hybrid Heparin-Bonded Nitinol and eptfe Stent in the treatment of popliteal artery occlusion: mid- term follow-up results. Wronski J. 1), 2) 3), Wilczynski M 1), Gembal P 1), Milik K 1), Dec St 1), Grybos
More informationExpanding to every demand: The GORE VIABAHN VBX Stent Graft
Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD
More informationLate outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent
From the New England Society for Vascular Surgery Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,
More informationVČASNÁ KAROTICKÁ ENDARTEREKTÓMIA NAŠE SKÚSENOSTI. Kuročka M., Beňo P., Rusňák M., Rusňák F. KCCH ÚVN SNP Ružomberok - FN
VČASNÁ KAROTICKÁ ENDARTEREKTÓMIA NAŠE SKÚSENOSTI Kuročka M., Beňo P., Rusňák M., Rusňák F. KCCH ÚVN SNP Ružomberok - FN ISCHEMICKÁ CMP Náhla porucha cirkulácie krvi v mozgu, vyvolávajúca nekrózu mozgového
More informationThe Final Triumph Of Endovascular Therapy In SFA Treatment
The Final Triumph Of Endovascular Therapy In SFA Treatment MEET 07 Mark W. Mewissen, M.D. Director, St Lukes Vascular Center Milwaukee, WI Endovascular Therapy In SFA Treatment: Works In Progress! Mark
More informationClinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases
Original paper Clinical and morphological features of patients who underwent endovascular interventions for lower extremity arterial occlusive diseases Sakir Arslan, Isa Oner Yuksel, Erkan Koklu, Goksel
More informationHybrid Procedures for Peripheral Obstructive Disease - Step by Step -
Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have
More informationJohn E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationLong-Term Outcome After Percutaneous Peripheral Intervention vs Medical Treatment for Patients With Superficial Femoral Artery Occlusive Disease
Circ J 2008; 72: 734 739 Long-Term Outcome After Percutaneous Peripheral ntervention vs Medical Treatment for Patients With Superficial Femoral Artery Occlusive Disease Chizuko Kamiya, MD; Shingo Sakamoto,
More informationPAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
More informationEfficacy of Cilostazol After Endovascular Therapy for Femoropopliteal Artery Disease in Patients With Intermittent Claudication
Journal of the American College of Cardiology Vol. 53, No. 1, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.09.020
More informationLong-term results of open and endovascular revascularization of superficial femoral artery occlusive disease
From the New England Society for Vascular Surgery Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease Salvatore T. Scali, MD, a Eva M. Rzucidlo,
More informationInterventional Treatment First for CLI
Interventional Treatment First for CLI Patrick Alexander, MD, FACC, FSCAI Interventional Cardiology Medical Director, Critical Limb Clinic Providence Heart Institute, Southfield MI 48075 Disclosures Consultant
More informationPatterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy
From the Society for Clinical Vascular Surgery Patterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy Misaki M. Kiguchi, MD, MBA, a Luke K. Marone, MD, a Rabih
More informationKeywords Infrared thermography, percutaneous transluminal angioplasty, peripheral arterial disease, ankle-brachial index
Original Article Infrared thermography as option for evaluating the treatment effect of percutaneous transluminal angioplasty by patients with peripheral arterial disease Vascular 2017, Vol. 25(1) 42 49!
More informationEndovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
More informationMaximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia
Maximally Invasive Vascular Surgery for the Treatment of Critical Limb Ischemia Traci A. Kimball, MD Department of Surgery Grand Rounds Septemember 13, 2010 Overview Defining Critical Limb Ischemia Epidemiology
More information3-year results of the OLIVE registry:
3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure
More informationUvA-DARE (Digital Academic Repository) Diagnosis and treatment of critical limb ischemia Met, R. Link to publication
UvA-DARE (Digital Academic Repository) Diagnosis and treatment of critical limb ischemia Met, R. Link to publication Citation for published version (APA): Met, R. (2010). Diagnosis and treatment of critical
More informationPopliteal Bypass Versus Percutaneous Transluminal
501591SJS102410.1177/1457496913501591The treatment of occlusive superficial femoral artery diseaseh. Linnakoski, et al. 2013 ORIGINAL ARTICLE Scandinavian Journal of Surgery 102: 227 233, 2013 Comparison
More informationVčasná karotická endarterektómia
Včasná karotická endarterektómia Písomna práca k špecializačnej skúške z cievnej chirurgie Vedúci: Prof. MUDr. Vladimír Šefránek, PhD. MUDr. Ján Tomka, PhD., MHA Bratislava 2015 MUDr. Martin Kuročka KCCH
More informationStratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery
More informationPoor Inter-observer Agreement on the TASC II Classification of Femoropopliteal Lesions *
Eur J Vasc Endovasc Surg (2010) 39, 220e224 Poor Inter-observer Agreement on the TASC II Classification of Femoropopliteal Lesions * T. Kukkonen a, *, M. Korhonen b, K. Halmesmäki a, L. Lehti b, M. Tiitola
More informationSurgery is and Remains the Gold Standard for Limb-Threatening Ischemia
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you
More informationEvidence-Based Optimal Treatment for SFA Disease
Evidence-Based Optimal Treatment for SFA Disease Endo first Don t burn surgical bridge Don t stent if possible Javairiah Fatima, MD Assistant Professor of Surgery Division of Vascular and Endovascular
More informationDisclosures. TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Purpose of Practice Guidelines
TASC, AHA, SVS: What s Happening with the Guidelines? How Are They Relevant? Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center UCSF Medical
More informationImaging Strategy For Claudication
Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon
More informationPractical Point in Diabetic Foot Care 3-4 July 2017
Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University
More informationIsolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention
From the Eastern Vascular Society Isolated femoral endarterectomy: Impact of SFA TASC classification on recurrence of symptoms and need for additional intervention Georges Al-Khoury, MD, Luke Marone, MD,
More informationSilvia Bleda, Joaquin de Haro, Cesar Varela, Ignacio Lopez de Maturana, Javier Rodriguez, and Francisco Acin
ISRN Vascular Medicine Volume 2013, Article ID 219479, 7 pages http://dx.doi.org/10.1155/2013/219479 Research Article Inflammatory Burden but Not Diabetes Mellitus Influences in Prognosis of Endovascular
More informationTHE NEW ARMENIAN MEDICAL JOURNAL
THE NEW ARMENIAN MEDICAL JOURNAL Vol.10 (2016), Nо 1, p. 57-62 Clinical Research SHORT-TERM OUTCOMES OF ENDOVASCULAR INTERVENTION OF INFRAINGUINAL ARTERIES IN PATIENTS WITH CRITICAL LIMB ISCHEMIA Sultanyan
More informationOriginal article * Originálny článok Cardiology Lett. 2017;26(2):69 82
Original article * Originálny článok Cardiology Lett. 2017;26(2):69 82 Indikujeme adekvátne invazívnu diagnostiku u pacientov s NSTE-AKS? Analýza výsledkov registra SLOVAKS-2 z roku 2015 Kovář F 1, Studenčan
More informationClinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia
From the Society for Clinical Vascular Surgery Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia Hasan H. Dosluoglu,
More informationLimb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017
Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene
More informationBypass Surgery vs. Drug-Eluting Stent for Trans-Atlantic Inter-Society Consensus-II (TASCII) C or D Femoropopliteal Lesions
2688 SOGA Y et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Peripheral Vascular Disease Bypass Surgery vs. Drug-Eluting Stent for
More informationJohn E. Campbell, MD. Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationCritical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017
Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral
More informationTurboHawk. Plaque Excision System
TurboHawk Plaque Excision System Twelve-month Patency in Diabetics DIABETICS VS. NON-DIABETICS 12-month Primary Patency (%) Diabetic patients show a more positive response to directional atherectomy than
More information[HR], %, 66.7%, 63.1%, 90.4%, 87.3%, 86.2% 1, 3, 5 53 (10%) 38% 14%. 0.52; P
Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent Yoshimitsu Soga, MD, a Osamu Iida, MD, b Keisuke Hirano, MD, c Hiroyohi Yokoi,
More informationCase Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel
Case Reports in Vascular Medicine Volume 2015, Article ID 725168, 4 pages http://dx.doi.org/10.1155/2015/725168 Case Report Successful Implantation of a Coronary Stent Graft in a Peripheral Vessel Alexander
More informationAre RCT always needed: Experience with objective performance criteria (OPC)
Are RCT always needed: Experience with objective performance criteria (OPC) Peter A. Schneider, MD Krishna Rocha-Singh, MD Kaiser Foundation Hospital Honolulu, Hawaii Prarie Heart Institute Springfield,
More informationvs 39 p = 0.01 PTA STENT Tel:
13 537543 24 1 FF1 19 FF 45 66 1521 81 85 65 1 vs 88 vs 56 p =.4 8mm vs 6mm 91 vs p =.4 S vs C 89 vs 39 p =.1 6mm 8mm 9 FF 8mm 13 537543 24 1 FF 1 2 3 PTA STENT TASC 3cm Tel: 76-472-1212 93-391 51 23 11
More informationNitinol stent implantation in chronic limb ischemia secondary to iliac artery narrowing
RESEARCH ARTICLE Nitinol stent implantation in chronic limb ischemia secondary to iliac artery narrowing Hammad A 1*, Modaber AMA 1, Aliyev V 2 Hammad A, Modaber AMA, Aliyev V. Nitinol stent implantation
More informationFemoropopliteal Above-Knee Bypass: The True Results
Femoropopliteal Above-Knee Bypass: The True Results Lise Pyndt Jørgensen, Camilla Rasmussen & Torben V Schroeder Rigshospitalet and University of Copenhagen, DENMARK Treatment options in the femoropopliteal
More informationPrevalence, Progression and Associated Risk Factors of Asymptomatic Peripheral Arterial Disease
ORIGINAL PAPER ORIGINAL PAPER The ANNALS of AFRICAN SURGERY www.annalsofafricansurgery.com Prevalence, Progression and Associated Risk Factors of Asymptomatic Peripheral Arterial Disease Nikita Mehta 1,
More informationManaging Conditions Resulting from Untreated Cardiometabolic Syndrome
Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb
More informationWhat s New in the Management of Peripheral Arterial Disease
What s New in the Management of Peripheral Arterial Disease Sibu P. Saha, MD, MBA Professor of Surgery Chairman, Directors Council Gill Heart Institute University of Kentucky Lexington, KY Disclosure My
More informationCritical Limb Ischemia: Diagnosis and Current Management
Research Article Joseph Karam, MD Elliot J. Stephenson, MD From: Minneapolis Heart Institutet at Abbott Northwestern Hospital, Minneapolis, MN Address for correspondence: Joseph Karam, MD Minneapolis Heart
More informationEndovascular intervention for patients with femoro-popliteal and aorto-iliac TASC D lesions
Endovascular intervention for patients with femoro-popliteal and aorto-iliac TASC D lesions Poster No.: C-2012 Congress: ECR 2014 Type: Educational Exhibit Authors: E. Thomee, W. C. Liong, D. R. Warakaulle;
More informationDepartment of Cardiology, The Cardiovascular Institute, Roppongi, Minato-ku, Tokyo, , Japan
Journal of Cardiology (2009) 53, 417 421 ORIGINAL ARTICLE Clinical outcomes after percutaneous peripheral intervention for chronic total occlusion of superficial femoral arteries: Comparison between self-expandable
More informationDrug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience
Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience Maria Doyle, M.Eng; Hilary Coffey, M.D. Ravindra Gullipalli, MBBS, FRCR St. Clare s Mercy
More informationOutcomes after endovascular intervention for chronic critical limb ischemia
From the Eastern Vascular Society Outcomes after endovascular intervention for chronic critical limb ischemia Monica S. O Brien-Irr, MS, RN, a Hasan H. Dosluoglu, MD, a Linda M. Harris, MD, a,b and Maciej
More informationPeriférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko
prehľadové práce přehledové práce reviews 21 Periférne artériové ochorenie dolných končatín a globálne kardiovaskulárne riziko Peripheral arterial disease of lower extremity and global cardiovascular risk
More informationEndovascular treatment of common femoral artery obstructions
Endovascular treatment of common femoral artery obstructions Frederic Baumann, MD, a Mirka Ruch, a Torsten Willenberg, MD, a Florian Dick, MD, b Dai-Do Do, MD, a Hak-Hong Keo, MD, a Iris Baumgartner, MD,
More informationNational Clinical Conference 2018 Baltimore, MD
National Clinical Conference 2018 Baltimore, MD No relevant financial relationships to disclose Wound Care Referral The patient has been maximized from a vascular standpoint. She has no other options.
More informationNorth American Society of Cardiovascular Imaging Annual Meeting, Baltimore MD, October 15-18, Tips and Tricks in Vascular Imaging
North American Society of Cardiovascular Imaging Annual Meeting, Baltimore MD, October 15-18, 2016 Tips and Tricks in Vascular Imaging Lower Extremity CTA Dominik Fleischmann, Richard Hallett Division
More informationViabahn for femoropopliteal in-stent restenosis
Viabahn for femoropopliteal in-stent restenosis Owayed Al Shammeri, a Fahad Bitar, b Jaime Ghitelman, c Peter A. Soukas d From the a Medicine, Qassim University, Buraidah, Saudi Arabia, b Cardiology, Tufts
More informationPATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE
PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential
More informationFrom the Peripheral Vascular Surgery Society
From the Peripheral Vascular Surgery Society Comparison of initial hemodynamic response after endovascular therapy and open surgical bypass in patients with diabetes mellitus and critical limb ischemia
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationDisclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention
In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE
More informationThe Impact of Peripheral Artery Disease on Health Related Quality of Life: Comparison with the Impact of Coronary Artery Disease
Research Article imedpub Journals www.imedpub.com Journal of Vascular and Endovascular Surgery DOI: 10.21767/2573-4482.100060 The Impact of Peripheral Artery Disease on Health Related Quality of Life:
More informationThe Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology
The Crack and Pave technique for highly resistant calcified lesions Manuela Matschuck MD University Hospital Leipzig Department Angiology Disclosure Speaker name: Dr. med. Manuela Matschuck I have the
More informationProgression of asymptomatic peripheral artery disease over 1 year
1106VMJ17110.1177/1358863X11431106Vascular MedicineMohler ER III et al. Progression of asymptomatic peripheral artery disease over 1 year Vascular Medicine 17(1) 10 16 The Author(s) 2012 Reprints and permission:
More informationHybrid Endarterectomy and Endovascular Therapy in Multilevel Lower Extremity Arterial Disease Involving the Femoral Artery Bifurcation
Int Surg 2012;97:56 64 Hybrid Endarterectomy and Endovascular Therapy in Multilevel Lower Extremity Arterial Disease Involving the Femoral Artery Bifurcation Junjie Zou 1, Yongxiang Xia 2, Hongyu Yang
More informationEndovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease
Endovascular and Hybrid Treatment of TASC C & D Aortoiliac Occlusive Disease Arash Bornak, MD FACS Vascular & Endovascular Surgery University of Miami Miller School of Medicine No disclosure BACKGROUND
More informationAngiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-
Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis- Masahiko Fujihara Kishiwada Tokushukai Hospital, Osaka, Japan Disclosure
More informationSpecificities for infrapopliteal stents
Specificities for infrapopliteal stents Nicolas Diehm, M.D. Swiss Cardiovascular Center Clinical and Interventional Angiology University Hospital Bern, Switzerland Disclosures Speaker`s Bureau: MEDRAD,
More informationRC 612B 3 December Richard L. Hallett, MD
RC 612B 3 December 2015 0830 1000 Richard L. Hallett, MD Chief, Cardiovascular Imaging Northwest Radiology Network Indianapolis, IN Adjunct Assistant Professor Radiology Stanford University Stanford, CA
More informationEarly Identification of PAD: Evidence to Refute USPSTF Position on Screening
Early Identification of PAD: Evidence to Refute USPSTF Position on Screening Mehdi H. Shishehbor, DO, MPH, PhD Director Endovascular Services Interventional Cardiology & Vascular Medicine Department of
More informationTools and options for recanalisation of long-femoro-popliteal segments
Tools and options for recanalisation of long-femoro-popliteal segments Pr E Ducasse Unit of Vascular Surgery University of Bordeaux ESVB 2011-may 14th E Ducasse, G Sassoust, D Midy THE ACCESS!! Retrograde
More informationComparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts
ORIGINAL ARTICLE pissn 2288-6575 eissn 2288-6796 http://dx.doi.org/10.4174/astr.2015.88.1.28 Annals of Surgical Treatment and Research Comparison of long-term results of above-the-knee femoro-popliteal
More informationStenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease
From the Society for Clinical Vascular Surgery Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H. Dosluoglu,
More informationstent placement for TASC-II C/D disease compared with TASC-II A/B.
Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II Shigeo Ichihashi, MD, a Wataru
More informationLower extremity arterial thromboembolism leads to sudden interruption
Diagn Interv Radiol 2010; 16:79 83 Turkish Society of Radiology 2010 INTERVENTIONAL RADIOLOGY ORIGINAL ARTICLE Percutaneous aspiration thrombectomy in the treatment of lower extremity thromboembolic occlusions
More informationNové znenie informácií o lieku výňatky z odporúčaní výboru PRAC týkajúcich sa signálov
25 January 2018 EMA/PRAC/35594/2018 Corr 1 Pharmacovigilance Risk Assessment Committee (PRAC) Nové znenie informácií o lieku výňatky z odporúčaní výboru PRAC týkajúcich sa signálov Prijaté na zasadnutí
More informationDiagnosis and management of pheripheral arterial occlusive disease
Original article : Diagnosis and management of pheripheral arterial occlusive disease 1 Dr Shrikant kurhade, 2 Dr Pravin Namdeo shingade 1,2 Assistant Professor, Grant Govt Medical College & Sir J J Group
More informationDistal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff
Distal hybrids - an option in long SFA CTO accompanied by severely compromized crural runoff P. Kuryanov, A. Lipin, A. Antropov, K. Atmadzas, A. Atmadzas, Y. Eminov, A. Borisov, R. Sobolev, A.Orlov Limb
More informationVascular Protection in Patients with CAD and PAD: New Options
Vascular Protection in Patients with CAD and PAD: New Options Professor Dr Eike Sebastian Debus Direktor Klinik für Gefäßmedizin Gefäßchirurgie Angiologie Interventionelle Therapie Deutsches Aortenzentrum
More informationDisclosures. Objectives. Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach. Christopher D. Owens, MD 4/23/2009
Disclosures Bypass vs. Endo for SFA Disease: Reaching Consensus on a Rational Approach No disclosures No conflicts of interest Christopher D. Owens, MD Objectives Changing face of our patients presenting
More informationNADINE R. BARSOUM, M.D.; LAMIAA I.A. METWALLY, M.D. and IMAN M. HAMDY IBRAHIM, M.D.
Med. J. Cairo Univ., Vol. 84, No. 2, December: 175-183, 2016 www.medicaljournalofcairouniversity.net Peripheral Arterial Disease of the Lower Limbs: Is Doppler Examination as Efficient in its Diagnosis
More informationjournal of medicine The new england Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery Abstract
The new england journal of medicine established in 1812 may 4, 2006 vol. 354 no. 18 Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery Martin Schillinger, M.D.,
More information